In This Article:
Amid heightened global trade tensions and economic uncertainty, Asian markets are navigating a complex landscape influenced by recent tariff announcements and their potential impacts on growth. In such an environment, identifying stocks that may be trading below their estimated value can present opportunities for investors seeking to capitalize on market inefficiencies.
Top 10 Undervalued Stocks Based On Cash Flows In Asia
Name | Current Price | Fair Value (Est) | Discount (Est) |
Alexander Marine (TWSE:8478) | NT$141.50 | NT$280.52 | 49.6% |
SNT Energy (KOSE:A100840) | ₩30150.00 | ₩58803.24 | 48.7% |
Xiamen Amoytop Biotech (SHSE:688278) | CN¥74.19 | CN¥148.31 | 50% |
Micro-Star International (TWSE:2377) | NT$137.00 | NT$266.10 | 48.5% |
BuySell TechnologiesLtd (TSE:7685) | ¥2534.00 | ¥5008.67 | 49.4% |
internet infinity (TSE:6545) | ¥577.00 | ¥1139.50 | 49.4% |
Sichuan Jiuyuan Yinhai Software.Co.Ltd (SZSE:002777) | CN¥15.90 | CN¥31.03 | 48.8% |
North Electro-OpticLtd (SHSE:600184) | CN¥11.23 | CN¥21.97 | 48.9% |
Zhende Medical (SHSE:603301) | CN¥19.90 | CN¥38.71 | 48.6% |
SFA Semicon (KOSDAQ:A036540) | ₩2645.00 | ₩5249.51 | 49.6% |
Here we highlight a subset of our preferred stocks from the screener.
JINS HOLDINGS
Overview: JINS HOLDINGS Inc. operates in the planning, manufacturing, sales, and import/export of eyewear and fashion accessories both in Japan and internationally, with a market cap of ¥154.75 billion.
Operations: The company's revenue is derived from its Domestic Eye Wear Business, contributing ¥67.96 billion, and its Overseas Eyewear Business, which adds ¥19.10 billion.
Estimated Discount To Fair Value: 13.5%
JINS HOLDINGS is trading at ¥6,630, below its estimated fair value of ¥7,666.49, suggesting potential undervaluation based on cash flows. Earnings are forecast to grow at 14.3% annually, outpacing the JP market's 7.8%. Recent sales reports show robust growth with March all-store sales up 21.7% year-over-year and existing store sales increasing by 18.5%, indicating strong operational performance amidst favorable revenue growth projections of 7.7% per year.
Mandom
Overview: Mandom Corporation manufactures and sells cosmetics, perfumes, and quasi-drugs in Japan, Indonesia, and internationally with a market cap of ¥57.55 billion.
Operations: The company's revenue segments are comprised of ¥45.99 billion from Japan, ¥17.92 billion from Indonesia, and ¥22.06 billion from other overseas markets.